Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Case Report

Adenoid Cystic Carcinoma of the Breast

Author(s): Yun-Chung Cheung*, Shir-Hwa Ueng, Shu-Hang Ng and Wen-Lin Kuo

Volume 17, Issue 4, 2021

Published on: 09 October, 2020

Page: [539 - 543] Pages: 5

DOI: 10.2174/1573405616666201009144337

Price: $65

Abstract

Background: Contrast-enhanced spectral mammogram (CESM) is a modern technique providing additional information to detect or diagnose breast cancers.

Introduction: We present a rare ACC of the breast on CESM.

Methods: A 49-year-old woman with surgicopathological proved ACC was reported with tumor features on CESM, sonography and contrast-enhanced magnetic resonance imaging (CE-MRI).

Results: Sonography revealed a 1.4 cm × 1.2 cm × 1 cm circumscribe round mass in the upper outer quadrant of the left breast that was diagnosed with fibroadenoma. The mammogram did not show any discernible mass, however, the recombined subtracted images displayed a circumscribe mass with thin rim enhancement and enhanced internal patches that were resembling CE-MRI. Finally, the mass was proved to ACC.

Conclusion: CESM facilitates the detection of isodense cancer and provides the enhanced features for differential diagnosis. Resembling CE-MRI, CESM displayed rim enhancement and internal enhanced patches as diagnostic clues for this case of ACC.

Keywords: Adenoid cystic carcinoma, breast cancer, contrast-enhanced spectral mammography, mammography, contrast-enhanced magnetic resonance imaging, metastasis.

Graphical Abstract
[1]
Kulkarni N, Pezzi CM, Greif JM, et al. Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base. Ann Surg Oncol 2013; 20(7): 2236-41.
[http://dx.doi.org/10.1245/s10434-013-2911-z] [PMID: 23456318]
[2]
Geschickter C. Diseases of the breast: diagnosis, pathology, treatment. 2nd ed. Philadelphia: Lippincott 1945.
[http://dx.doi.org/10.1097/00000441-194511000-00032]
[3]
Soon SR, Yong WS, Ho GH, Wong CY, Ho BC, Tan PH. Adenoid cystic breast carcinoma: a salivary gland-type tumour with excellent prognosis and implications for management. Pathology 2008; 40(4): 413-5.
[http://dx.doi.org/10.1080/00313020802036830] [PMID: 18446636]
[4]
Boujelbene N, Khabir A, Boujelbene N, Jeanneret Sozzi W, Mirimanoff RO, Khanfir K. Clinical review--breast adenoid cystic carcinoma. Breast 2012; 21(2): 124-7.
[http://dx.doi.org/10.1016/j.breast.2011.11.006] [PMID: 22154460]
[5]
Kim M, Lee DW, Im J, et al. Adenoid cystic carcinoma of the breast: a case series of six patients and literature review. Cancer Res Treat 2014; 46(1): 93-7.
[http://dx.doi.org/10.4143/crt.2014.46.1.93] [PMID: 24520228]
[6]
Tang W, Peng WJ, Gu YJ, Zhu H, Jiang TT, Li C. Imaging manifestation of adenoid cystic carcinoma of the breast. J Comput Assist Tomogr 2015; 39(4): 523-30.
[http://dx.doi.org/10.1097/RCT.0000000000000236] [PMID: 25836024]
[7]
Glazebrook KN, Reynolds C, Smith RL, Gimenez EI, Boughey JC. Adenoid cystic carcinoma of the breast. AJR Am J Roentgenol 2010; 194(5): 1391-6.
[http://dx.doi.org/10.2214/AJR.09.3545] [PMID: 20410430]
[8]
Defaud-Hénon F, Tunon-de-Lara C, Fournier M, et al. [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]. Ann Pathol 2010; 30(1): 7-16.
[PMID: 20223349]
[9]
Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res 2010; 12(4): R54.
[http://dx.doi.org/10.1186/bcr2613] [PMID: 20653964]
[10]
Marchiò C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas). J Clin Pathol 2010; 63(3): 220-8.
[http://dx.doi.org/10.1136/jcp.2009.073908] [PMID: 20203221]
[11]
Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer 2002; 94(8): 2119-27.
[http://dx.doi.org/10.1002/cncr.10455] [PMID: 12001107]
[12]
Cheung YC, Lin YC, Wan YL, et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis. Eur Radiol 2014; 24(10): 2394-403.
[http://dx.doi.org/10.1007/s00330-014-3271-1] [PMID: 24928280]
[13]
Mori M, Akashi-Tanaka S, Suzuki S, et al. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts. Breast Cancer 2017; 24(1): 104-10.
[http://dx.doi.org/10.1007/s12282-016-0681-8] [PMID: 26942415]
[14]
Jochelson MS, Dershaw DD, Sung JS, et al. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013; 266(3): 743-51.
[http://dx.doi.org/10.1148/radiol.12121084] [PMID: 23220903]
[15]
Cheung YC, Tsai HP, Lo YF, Ueng SH, Huang PC, Chen SC. Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis. Eur Radiol 2016; 26(4): 1082-9.
[http://dx.doi.org/10.1007/s00330-015-3904-z] [PMID: 26159872]
[16]
Bliznakova K, Kolitsi Z, Pallikarakis N. Dual-energy mammography: simulation studies. Phys Med Biol 2006; 51(18): 4497-515.
[http://dx.doi.org/10.1088/0031-9155/51/18/004] [PMID: 16953039]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy